nodes	percent_of_prediction	percent_of_DWPC	metapath
Etodolac—PTGS1—Ifosfamide—germ cell cancer	0.167	0.268	CbGbCtD
Etodolac—PTGS2—Cisplatin—germ cell cancer	0.0963	0.154	CbGbCtD
Etodolac—PTGS2—Etoposide—germ cell cancer	0.0946	0.152	CbGbCtD
Etodolac—PTGS1—Etoposide—germ cell cancer	0.0799	0.128	CbGbCtD
Etodolac—CYP2C9—Ifosfamide—germ cell cancer	0.0673	0.108	CbGbCtD
Etodolac—SLC22A6—Methotrexate—germ cell cancer	0.0463	0.0742	CbGbCtD
Etodolac—ALB—Methotrexate—germ cell cancer	0.0394	0.0632	CbGbCtD
Etodolac—CYP2C9—Cisplatin—germ cell cancer	0.0327	0.0525	CbGbCtD
Etodolac—CYP2C9—cardial valve—germ cell cancer	0.0108	0.177	CbGeAlD
Etodolac—RXRA—ganglion—germ cell cancer	0.00652	0.107	CbGeAlD
Etodolac—UGT1A10—Metapathway biotransformation—NAT9—germ cell cancer	0.00566	0.104	CbGpPWpGaD
Etodolac—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00336	0.0617	CbGpPWpGaD
Etodolac—RXRA—Import of palmitoyl-CoA into the mitochondrial matrix—CRABP1—germ cell cancer	0.00312	0.0573	CbGpPWpGaD
Etodolac—RXRA—Nuclear Receptors—NR0B1—germ cell cancer	0.00279	0.0511	CbGpPWpGaD
Etodolac—UGT1A10—endocrine gland—germ cell cancer	0.00266	0.0438	CbGeAlD
Etodolac—RXRA—Regulation of pyruvate dehydrogenase (PDH) complex—CRABP1—germ cell cancer	0.00264	0.0485	CbGpPWpGaD
Etodolac—RXRA—telencephalon—germ cell cancer	0.00252	0.0414	CbGeAlD
Etodolac—CYP2C9—urine—germ cell cancer	0.00232	0.0382	CbGeAlD
Etodolac—UGT1A3—Metapathway biotransformation—NAT9—germ cell cancer	0.00225	0.0414	CbGpPWpGaD
Etodolac—RXRA—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.0022	0.0404	CbGpPWpGaD
Etodolac—RXRA—Regulation of Androgen receptor activity—NR0B1—germ cell cancer	0.00213	0.0392	CbGpPWpGaD
Etodolac—PTGS2—appendage—germ cell cancer	0.00197	0.0324	CbGeAlD
Etodolac—UGT2B7—Metapathway biotransformation—NAT9—germ cell cancer	0.00192	0.0352	CbGpPWpGaD
Etodolac—RXRA—Pyruvate metabolism—CRABP1—germ cell cancer	0.00191	0.0351	CbGpPWpGaD
Etodolac—UGT1A3—endocrine gland—germ cell cancer	0.00187	0.0309	CbGeAlD
Etodolac—RXRA—female gonad—germ cell cancer	0.00171	0.0281	CbGeAlD
Etodolac—PTGS2—skin epidermis—germ cell cancer	0.00164	0.027	CbGeAlD
Etodolac—RXRA—endocrine gland—germ cell cancer	0.00159	0.0261	CbGeAlD
Etodolac—RXRA—head—germ cell cancer	0.00157	0.0258	CbGeAlD
Etodolac—UGT1A9—Metapathway biotransformation—NAT9—germ cell cancer	0.00156	0.0286	CbGpPWpGaD
Etodolac—PTGS1—ganglion—germ cell cancer	0.00144	0.0238	CbGeAlD
Etodolac—RXRA—a6b1 and a6b4 Integrin signaling—CD9—germ cell cancer	0.0014	0.0257	CbGpPWpGaD
Etodolac—UGT1A9—endocrine gland—germ cell cancer	0.00134	0.022	CbGeAlD
Etodolac—PTGS1—endothelium—germ cell cancer	0.00124	0.0205	CbGeAlD
Etodolac—RXRA—Vitamin A and Carotenoid Metabolism—CRABP1—germ cell cancer	0.0012	0.022	CbGpPWpGaD
Etodolac—PTGS2—endothelium—germ cell cancer	0.00119	0.0196	CbGeAlD
Etodolac—RXRA—Pyruvate metabolism and Citric Acid (TCA) cycle—CRABP1—germ cell cancer	0.00116	0.0212	CbGpPWpGaD
Etodolac—PTGS1—blood vessel—germ cell cancer	0.00115	0.0189	CbGeAlD
Etodolac—RXRA—brain—germ cell cancer	0.00114	0.0187	CbGeAlD
Etodolac—PTGS2—blood vessel—germ cell cancer	0.0011	0.0181	CbGeAlD
Etodolac—UGT2B7—endocrine gland—germ cell cancer	0.00108	0.0177	CbGeAlD
Etodolac—RXRA—Transcriptional regulation of white adipocyte differentiation—KLF4—germ cell cancer	0.00104	0.0191	CbGpPWpGaD
Etodolac—UGT2B7—testis—germ cell cancer	0.00103	0.0169	CbGeAlD
Etodolac—ALB—Transport of organic anions—AVP—germ cell cancer	0.000935	0.0172	CbGpPWpGaD
Etodolac—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—germ cell cancer	0.000777	0.0143	CbGpPWpGaD
Etodolac—ALB—adrenal gland—germ cell cancer	0.000711	0.0117	CbGeAlD
Etodolac—UGT1A3—NRF2 pathway—SLC2A3—germ cell cancer	0.000708	0.013	CbGpPWpGaD
Etodolac—SLC22A6—brain—germ cell cancer	0.000707	0.0116	CbGeAlD
Etodolac—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000683	0.0125	CbGpPWpGaD
Etodolac—PTGS2—trigeminal ganglion—germ cell cancer	0.000678	0.0112	CbGeAlD
Etodolac—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000673	0.0124	CbGpPWpGaD
Etodolac—CYP2C9—Metapathway biotransformation—NAT9—germ cell cancer	0.000668	0.0123	CbGpPWpGaD
Etodolac—PTGS2—embryo—germ cell cancer	0.000654	0.0108	CbGeAlD
Etodolac—UGT2B7—NRF2 pathway—SLC2A3—germ cell cancer	0.000602	0.0111	CbGpPWpGaD
Etodolac—ALB—testis—germ cell cancer	0.000588	0.00967	CbGeAlD
Etodolac—RXRA—Circadian Clock—AVP—germ cell cancer	0.000566	0.0104	CbGpPWpGaD
Etodolac—RXRA—NRF2 pathway—SLC2A3—germ cell cancer	0.000562	0.0103	CbGpPWpGaD
Etodolac—PTGS1—telencephalon—germ cell cancer	0.000557	0.00916	CbGeAlD
Etodolac—PTGS2—telencephalon—germ cell cancer	0.000532	0.00876	CbGeAlD
Etodolac—PTGS1—skin of body—germ cell cancer	0.000531	0.00875	CbGeAlD
Etodolac—Vision blurred—Ifosfamide—germ cell cancer	0.000525	0.00201	CcSEcCtD
Etodolac—Sepsis—Methotrexate—germ cell cancer	0.000523	0.00201	CcSEcCtD
Etodolac—Thrombocytopenia—Bleomycin—germ cell cancer	0.000521	0.002	CcSEcCtD
Etodolac—Feeling abnormal—Vinblastine—germ cell cancer	0.000519	0.00199	CcSEcCtD
Etodolac—Myalgia—Dactinomycin—germ cell cancer	0.000518	0.00198	CcSEcCtD
Etodolac—Ill-defined disorder—Ifosfamide—germ cell cancer	0.000517	0.00198	CcSEcCtD
Etodolac—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000515	0.00197	CcSEcCtD
Etodolac—Anaemia—Ifosfamide—germ cell cancer	0.000515	0.00197	CcSEcCtD
Etodolac—Tinnitus—Cisplatin—germ cell cancer	0.000515	0.00197	CcSEcCtD
Etodolac—Lymphadenopathy—Methotrexate—germ cell cancer	0.000513	0.00197	CcSEcCtD
Etodolac—Flushing—Cisplatin—germ cell cancer	0.000512	0.00196	CcSEcCtD
Etodolac—Discomfort—Dactinomycin—germ cell cancer	0.000512	0.00196	CcSEcCtD
Etodolac—Angioedema—Ifosfamide—germ cell cancer	0.000509	0.00195	CcSEcCtD
Etodolac—PTGS2—skin of body—germ cell cancer	0.000508	0.00836	CbGeAlD
Etodolac—Anorexia—Bleomycin—germ cell cancer	0.000507	0.00194	CcSEcCtD
Etodolac—Malaise—Ifosfamide—germ cell cancer	0.000503	0.00193	CcSEcCtD
Etodolac—Vertigo—Ifosfamide—germ cell cancer	0.000501	0.00192	CcSEcCtD
Etodolac—Leukopenia—Ifosfamide—germ cell cancer	0.000499	0.00191	CcSEcCtD
Etodolac—Photosensitivity—Methotrexate—germ cell cancer	0.000499	0.00191	CcSEcCtD
Etodolac—Polyuria—Methotrexate—germ cell cancer	0.000499	0.00191	CcSEcCtD
Etodolac—Abdominal pain—Vinblastine—germ cell cancer	0.000498	0.00191	CcSEcCtD
Etodolac—Hypotension—Bleomycin—germ cell cancer	0.000497	0.00191	CcSEcCtD
Etodolac—Oedema—Dactinomycin—germ cell cancer	0.000496	0.0019	CcSEcCtD
Etodolac—Infection—Dactinomycin—germ cell cancer	0.000493	0.00189	CcSEcCtD
Etodolac—Arrhythmia—Cisplatin—germ cell cancer	0.000493	0.00189	CcSEcCtD
Etodolac—Palpitations—Ifosfamide—germ cell cancer	0.000493	0.00189	CcSEcCtD
Etodolac—UGT1A9—NRF2 pathway—SLC2A3—germ cell cancer	0.000489	0.00898	CbGpPWpGaD
Etodolac—Alopecia—Cisplatin—germ cell cancer	0.000488	0.00187	CcSEcCtD
Etodolac—Hepatic failure—Methotrexate—germ cell cancer	0.000487	0.00187	CcSEcCtD
Etodolac—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000486	0.00186	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000485	0.00186	CcSEcCtD
Etodolac—Convulsion—Ifosfamide—germ cell cancer	0.000483	0.00185	CcSEcCtD
Etodolac—Hypertension—Ifosfamide—germ cell cancer	0.000481	0.00184	CcSEcCtD
Etodolac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A3—germ cell cancer	0.000479	0.00879	CbGpPWpGaD
Etodolac—Erythema multiforme—Etoposide—germ cell cancer	0.000478	0.00183	CcSEcCtD
Etodolac—Paraesthesia—Bleomycin—germ cell cancer	0.000478	0.00183	CcSEcCtD
Etodolac—Dyspnoea—Bleomycin—germ cell cancer	0.000475	0.00182	CcSEcCtD
Etodolac—Myalgia—Ifosfamide—germ cell cancer	0.000475	0.00182	CcSEcCtD
Etodolac—Arthralgia—Ifosfamide—germ cell cancer	0.000475	0.00182	CcSEcCtD
Etodolac—Flatulence—Cisplatin—germ cell cancer	0.000473	0.00181	CcSEcCtD
Etodolac—Anorexia—Dactinomycin—germ cell cancer	0.000473	0.00181	CcSEcCtD
Etodolac—Flushing—Etoposide—germ cell cancer	0.000469	0.0018	CcSEcCtD
Etodolac—Discomfort—Ifosfamide—germ cell cancer	0.000469	0.0018	CcSEcCtD
Etodolac—Hypersensitivity—Vinblastine—germ cell cancer	0.000464	0.00178	CcSEcCtD
Etodolac—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.000464	0.00178	CcSEcCtD
Etodolac—Decreased appetite—Bleomycin—germ cell cancer	0.000463	0.00177	CcSEcCtD
Etodolac—Visual disturbance—Methotrexate—germ cell cancer	0.000462	0.00177	CcSEcCtD
Etodolac—PTGS1—uterus—germ cell cancer	0.000462	0.0076	CbGeAlD
Etodolac—Confusional state—Ifosfamide—germ cell cancer	0.000459	0.00176	CcSEcCtD
Etodolac—Pain—Bleomycin—germ cell cancer	0.000455	0.00174	CcSEcCtD
Etodolac—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000455	0.00174	CcSEcCtD
Etodolac—Oedema—Ifosfamide—germ cell cancer	0.000455	0.00174	CcSEcCtD
Etodolac—Chills—Etoposide—germ cell cancer	0.000454	0.00174	CcSEcCtD
Etodolac—PTGS1—pituitary gland—germ cell cancer	0.000453	0.00746	CbGeAlD
Etodolac—Vision blurred—Cisplatin—germ cell cancer	0.000453	0.00173	CcSEcCtD
Etodolac—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.000452	0.00173	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000452	0.00173	CcSEcCtD
Etodolac—Asthenia—Vinblastine—germ cell cancer	0.000452	0.00173	CcSEcCtD
Etodolac—Infection—Ifosfamide—germ cell cancer	0.000452	0.00173	CcSEcCtD
Etodolac—Tremor—Cisplatin—germ cell cancer	0.00045	0.00172	CcSEcCtD
Etodolac—RXRA—The citric acid (TCA) cycle and respiratory electron transport—CRABP1—germ cell cancer	0.000448	0.00823	CbGpPWpGaD
Etodolac—Alopecia—Etoposide—germ cell cancer	0.000447	0.00171	CcSEcCtD
Etodolac—Cerebrovascular accident—Methotrexate—germ cell cancer	0.000447	0.00171	CcSEcCtD
Etodolac—Ill-defined disorder—Cisplatin—germ cell cancer	0.000446	0.00171	CcSEcCtD
Etodolac—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000445	0.00171	CcSEcCtD
Etodolac—Anaemia—Cisplatin—germ cell cancer	0.000444	0.0017	CcSEcCtD
Etodolac—PTGS2—uterus—germ cell cancer	0.000441	0.00726	CbGeAlD
Etodolac—ALB—brain—germ cell cancer	0.000441	0.00726	CbGeAlD
Etodolac—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00044	0.00168	CcSEcCtD
Etodolac—Feeling abnormal—Bleomycin—germ cell cancer	0.000439	0.00168	CcSEcCtD
Etodolac—Anorexia—Ifosfamide—germ cell cancer	0.000434	0.00166	CcSEcCtD
Etodolac—PTGS2—pituitary gland—germ cell cancer	0.000433	0.00713	CbGeAlD
Etodolac—Malaise—Cisplatin—germ cell cancer	0.000433	0.00166	CcSEcCtD
Etodolac—Decreased appetite—Dactinomycin—germ cell cancer	0.000432	0.00165	CcSEcCtD
Etodolac—Diarrhoea—Vinblastine—germ cell cancer	0.000431	0.00165	CcSEcCtD
Etodolac—Dysgeusia—Etoposide—germ cell cancer	0.000431	0.00165	CcSEcCtD
Etodolac—Leukopenia—Cisplatin—germ cell cancer	0.00043	0.00165	CcSEcCtD
Etodolac—Fatigue—Dactinomycin—germ cell cancer	0.000428	0.00164	CcSEcCtD
Etodolac—ALB—lymph node—germ cell cancer	0.000426	0.00701	CbGeAlD
Etodolac—Hypotension—Ifosfamide—germ cell cancer	0.000425	0.00163	CcSEcCtD
Etodolac—Pain—Dactinomycin—germ cell cancer	0.000425	0.00163	CcSEcCtD
Etodolac—Urticaria—Bleomycin—germ cell cancer	0.000423	0.00162	CcSEcCtD
Etodolac—Body temperature increased—Bleomycin—germ cell cancer	0.000421	0.00161	CcSEcCtD
Etodolac—PTGS2—medulla oblongata—germ cell cancer	0.000418	0.00688	CbGeAlD
Etodolac—Irritability—Methotrexate—germ cell cancer	0.000418	0.0016	CcSEcCtD
Etodolac—Dizziness—Vinblastine—germ cell cancer	0.000417	0.0016	CcSEcCtD
Etodolac—Convulsion—Cisplatin—germ cell cancer	0.000416	0.00159	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000414	0.00159	CcSEcCtD
Etodolac—Myalgia—Cisplatin—germ cell cancer	0.000409	0.00157	CcSEcCtD
Etodolac—Feeling abnormal—Dactinomycin—germ cell cancer	0.000409	0.00157	CcSEcCtD
Etodolac—Paraesthesia—Ifosfamide—germ cell cancer	0.000408	0.00156	CcSEcCtD
Etodolac—Ill-defined disorder—Etoposide—germ cell cancer	0.000408	0.00156	CcSEcCtD
Etodolac—Anxiety—Cisplatin—germ cell cancer	0.000408	0.00156	CcSEcCtD
Etodolac—Anaemia—Etoposide—germ cell cancer	0.000407	0.00156	CcSEcCtD
Etodolac—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000406	0.00156	CcSEcCtD
Etodolac—Dyspnoea—Ifosfamide—germ cell cancer	0.000406	0.00155	CcSEcCtD
Etodolac—PTGS1—adrenal gland—germ cell cancer	0.000405	0.00667	CbGeAlD
Etodolac—Somnolence—Ifosfamide—germ cell cancer	0.000404	0.00155	CcSEcCtD
Etodolac—Discomfort—Cisplatin—germ cell cancer	0.000404	0.00155	CcSEcCtD
Etodolac—ALB—Platelet degranulation—CD9—germ cell cancer	0.000402	0.00739	CbGpPWpGaD
Etodolac—Vomiting—Vinblastine—germ cell cancer	0.000401	0.00154	CcSEcCtD
Etodolac—Malaise—Etoposide—germ cell cancer	0.000397	0.00152	CcSEcCtD
Etodolac—RXRA—PPAR Alpha Pathway—MYC—germ cell cancer	0.000396	0.00726	CbGpPWpGaD
Etodolac—Vertigo—Etoposide—germ cell cancer	0.000396	0.00152	CcSEcCtD
Etodolac—Decreased appetite—Ifosfamide—germ cell cancer	0.000395	0.00151	CcSEcCtD
Etodolac—Headache—Vinblastine—germ cell cancer	0.000395	0.00151	CcSEcCtD
Etodolac—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.000394	0.00151	CcSEcCtD
Etodolac—Leukopenia—Etoposide—germ cell cancer	0.000394	0.00151	CcSEcCtD
Etodolac—Abdominal pain—Dactinomycin—germ cell cancer	0.000392	0.0015	CcSEcCtD
Etodolac—Body temperature increased—Dactinomycin—germ cell cancer	0.000392	0.0015	CcSEcCtD
Etodolac—Fatigue—Ifosfamide—germ cell cancer	0.000392	0.0015	CcSEcCtD
Etodolac—Oedema—Cisplatin—germ cell cancer	0.000392	0.0015	CcSEcCtD
Etodolac—Anaphylactic shock—Cisplatin—germ cell cancer	0.000392	0.0015	CcSEcCtD
Etodolac—Hypersensitivity—Bleomycin—germ cell cancer	0.000392	0.0015	CcSEcCtD
Etodolac—PTGS1—spinal cord—germ cell cancer	0.00039	0.00642	CbGeAlD
Etodolac—Infection—Cisplatin—germ cell cancer	0.00039	0.00149	CcSEcCtD
Etodolac—Pain—Ifosfamide—germ cell cancer	0.000389	0.00149	CcSEcCtD
Etodolac—Constipation—Ifosfamide—germ cell cancer	0.000389	0.00149	CcSEcCtD
Etodolac—PTGS2—adrenal gland—germ cell cancer	0.000387	0.00637	CbGeAlD
Etodolac—Loss of consciousness—Etoposide—germ cell cancer	0.000387	0.00148	CcSEcCtD
Etodolac—CYP2C9—endocrine gland—germ cell cancer	0.000385	0.00633	CbGeAlD
Etodolac—Thrombocytopenia—Cisplatin—germ cell cancer	0.000384	0.00147	CcSEcCtD
Etodolac—ALB—Response to elevated platelet cytosolic Ca2+—CD9—germ cell cancer	0.000383	0.00704	CbGpPWpGaD
Etodolac—Tachycardia—Cisplatin—germ cell cancer	0.000383	0.00147	CcSEcCtD
Etodolac—PTGS2—midbrain—germ cell cancer	0.000382	0.00629	CbGeAlD
Etodolac—Asthenia—Bleomycin—germ cell cancer	0.000382	0.00146	CcSEcCtD
Etodolac—Convulsion—Etoposide—germ cell cancer	0.000381	0.00146	CcSEcCtD
Etodolac—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—germ cell cancer	0.000381	0.007	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—TDGF1—germ cell cancer	0.000381	0.00699	CbGpPWpGaD
Etodolac—RXRA—Generic Transcription Pathway—NR0B1—germ cell cancer	0.00038	0.00698	CbGpPWpGaD
Etodolac—Hypertension—Etoposide—germ cell cancer	0.00038	0.00146	CcSEcCtD
Etodolac—Hyperhidrosis—Cisplatin—germ cell cancer	0.000379	0.00145	CcSEcCtD
Etodolac—Asthma—Methotrexate—germ cell cancer	0.000378	0.00145	CcSEcCtD
Etodolac—PTGS1—female gonad—germ cell cancer	0.000378	0.00622	CbGeAlD
Etodolac—Pruritus—Bleomycin—germ cell cancer	0.000377	0.00144	CcSEcCtD
Etodolac—Feeling abnormal—Ifosfamide—germ cell cancer	0.000375	0.00144	CcSEcCtD
Etodolac—Eosinophilia—Methotrexate—germ cell cancer	0.000375	0.00144	CcSEcCtD
Etodolac—PTGS2—bone marrow—germ cell cancer	0.000375	0.00616	CbGeAlD
Etodolac—Nausea—Vinblastine—germ cell cancer	0.000374	0.00143	CcSEcCtD
Etodolac—Anorexia—Cisplatin—germ cell cancer	0.000374	0.00143	CcSEcCtD
Etodolac—PTGS2—spinal cord—germ cell cancer	0.000373	0.00614	CbGeAlD
Etodolac—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000372	0.00143	CcSEcCtD
Etodolac—Pancreatitis—Methotrexate—germ cell cancer	0.000371	0.00142	CcSEcCtD
Etodolac—Discomfort—Etoposide—germ cell cancer	0.00037	0.00142	CcSEcCtD
Etodolac—Hypotension—Cisplatin—germ cell cancer	0.000366	0.0014	CcSEcCtD
Etodolac—Hypersensitivity—Dactinomycin—germ cell cancer	0.000366	0.0014	CcSEcCtD
Etodolac—Abdominal discomfort—Methotrexate—germ cell cancer	0.000363	0.00139	CcSEcCtD
Etodolac—Confusional state—Etoposide—germ cell cancer	0.000362	0.00139	CcSEcCtD
Etodolac—Urticaria—Ifosfamide—germ cell cancer	0.000361	0.00138	CcSEcCtD
Etodolac—PTGS2—female gonad—germ cell cancer	0.000361	0.00594	CbGeAlD
Etodolac—Body temperature increased—Ifosfamide—germ cell cancer	0.00036	0.00138	CcSEcCtD
Etodolac—Abdominal pain—Ifosfamide—germ cell cancer	0.00036	0.00138	CcSEcCtD
Etodolac—Pancytopenia—Methotrexate—germ cell cancer	0.000359	0.00138	CcSEcCtD
Etodolac—Anaphylactic shock—Etoposide—germ cell cancer	0.000359	0.00138	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000357	0.00137	CcSEcCtD
Etodolac—Infection—Etoposide—germ cell cancer	0.000357	0.00137	CcSEcCtD
Etodolac—Asthenia—Dactinomycin—germ cell cancer	0.000356	0.00136	CcSEcCtD
Etodolac—Neutropenia—Methotrexate—germ cell cancer	0.000354	0.00136	CcSEcCtD
Etodolac—Dysuria—Methotrexate—germ cell cancer	0.000354	0.00136	CcSEcCtD
Etodolac—Paraesthesia—Cisplatin—germ cell cancer	0.000352	0.00135	CcSEcCtD
Etodolac—Thrombocytopenia—Etoposide—germ cell cancer	0.000352	0.00135	CcSEcCtD
Etodolac—PTGS1—endocrine gland—germ cell cancer	0.000351	0.00578	CbGeAlD
Etodolac—Tachycardia—Etoposide—germ cell cancer	0.000351	0.00134	CcSEcCtD
Etodolac—Dyspnoea—Cisplatin—germ cell cancer	0.00035	0.00134	CcSEcCtD
Etodolac—Hyperhidrosis—Etoposide—germ cell cancer	0.000347	0.00133	CcSEcCtD
Etodolac—PTGS1—head—germ cell cancer	0.000347	0.00571	CbGeAlD
Etodolac—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—germ cell cancer	0.000347	0.00637	CbGpPWpGaD
Etodolac—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000345	0.00132	CcSEcCtD
Etodolac—UGT1A9—PPAR Alpha Pathway—MYC—germ cell cancer	0.000345	0.00633	CbGpPWpGaD
Etodolac—Anorexia—Etoposide—germ cell cancer	0.000342	0.00131	CcSEcCtD
Etodolac—Decreased appetite—Cisplatin—germ cell cancer	0.000341	0.00131	CcSEcCtD
Etodolac—Diarrhoea—Dactinomycin—germ cell cancer	0.00034	0.0013	CcSEcCtD
Etodolac—Pneumonia—Methotrexate—germ cell cancer	0.000339	0.0013	CcSEcCtD
Etodolac—Vomiting—Bleomycin—germ cell cancer	0.000338	0.0013	CcSEcCtD
Etodolac—PTGS2—endocrine gland—germ cell cancer	0.000336	0.00553	CbGeAlD
Etodolac—Hypotension—Etoposide—germ cell cancer	0.000336	0.00129	CcSEcCtD
Etodolac—Rash—Bleomycin—germ cell cancer	0.000336	0.00129	CcSEcCtD
Etodolac—Pain—Cisplatin—germ cell cancer	0.000335	0.00128	CcSEcCtD
Etodolac—Dermatitis—Bleomycin—germ cell cancer	0.000335	0.00128	CcSEcCtD
Etodolac—Hypersensitivity—Ifosfamide—germ cell cancer	0.000335	0.00128	CcSEcCtD
Etodolac—PTGS1—testis—germ cell cancer	0.000335	0.00551	CbGeAlD
Etodolac—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000335	0.00128	CcSEcCtD
Etodolac—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—germ cell cancer	0.000332	0.0061	CbGpPWpGaD
Etodolac—Renal failure—Methotrexate—germ cell cancer	0.000332	0.00127	CcSEcCtD
Etodolac—PTGS2—head—germ cell cancer	0.000331	0.00545	CbGeAlD
Etodolac—Stomatitis—Methotrexate—germ cell cancer	0.000329	0.00126	CcSEcCtD
Etodolac—Conjunctivitis—Methotrexate—germ cell cancer	0.000328	0.00126	CcSEcCtD
Etodolac—Asthenia—Ifosfamide—germ cell cancer	0.000326	0.00125	CcSEcCtD
Etodolac—RXRA—Developmental Biology—SALL4—germ cell cancer	0.000324	0.00594	CbGpPWpGaD
Etodolac—Sweating—Methotrexate—germ cell cancer	0.000323	0.00124	CcSEcCtD
Etodolac—Feeling abnormal—Cisplatin—germ cell cancer	0.000323	0.00124	CcSEcCtD
Etodolac—Paraesthesia—Etoposide—germ cell cancer	0.000323	0.00124	CcSEcCtD
Etodolac—Pruritus—Ifosfamide—germ cell cancer	0.000322	0.00123	CcSEcCtD
Etodolac—Haematuria—Methotrexate—germ cell cancer	0.000322	0.00123	CcSEcCtD
Etodolac—Dyspnoea—Etoposide—germ cell cancer	0.00032	0.00123	CcSEcCtD
Etodolac—Somnolence—Etoposide—germ cell cancer	0.000319	0.00122	CcSEcCtD
Etodolac—Nausea—Bleomycin—germ cell cancer	0.000316	0.00121	CcSEcCtD
Etodolac—Vomiting—Dactinomycin—germ cell cancer	0.000316	0.00121	CcSEcCtD
Etodolac—Agranulocytosis—Methotrexate—germ cell cancer	0.000315	0.00121	CcSEcCtD
Etodolac—Rash—Dactinomycin—germ cell cancer	0.000313	0.0012	CcSEcCtD
Etodolac—Decreased appetite—Etoposide—germ cell cancer	0.000312	0.0012	CcSEcCtD
Etodolac—Diarrhoea—Ifosfamide—germ cell cancer	0.000311	0.00119	CcSEcCtD
Etodolac—SLC22A6—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000311	0.0057	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—NANOG—germ cell cancer	0.00031	0.0057	CbGpPWpGaD
Etodolac—Body temperature increased—Cisplatin—germ cell cancer	0.00031	0.00119	CcSEcCtD
Etodolac—Fatigue—Etoposide—germ cell cancer	0.00031	0.00119	CcSEcCtD
Etodolac—Pain—Etoposide—germ cell cancer	0.000307	0.00118	CcSEcCtD
Etodolac—Constipation—Etoposide—germ cell cancer	0.000307	0.00118	CcSEcCtD
Etodolac—SLC22A6—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000306	0.00562	CbGpPWpGaD
Etodolac—Haemoglobin—Methotrexate—germ cell cancer	0.000304	0.00117	CcSEcCtD
Etodolac—Haemorrhage—Methotrexate—germ cell cancer	0.000303	0.00116	CcSEcCtD
Etodolac—Hepatitis—Methotrexate—germ cell cancer	0.000303	0.00116	CcSEcCtD
Etodolac—Dizziness—Ifosfamide—germ cell cancer	0.000301	0.00115	CcSEcCtD
Etodolac—Pharyngitis—Methotrexate—germ cell cancer	0.000301	0.00115	CcSEcCtD
Etodolac—RXRA—Developmental Biology—POU5F1—germ cell cancer	0.000299	0.00548	CbGpPWpGaD
Etodolac—Feeling abnormal—Etoposide—germ cell cancer	0.000296	0.00113	CcSEcCtD
Etodolac—PTGS2—cerebellum—germ cell cancer	0.000296	0.00487	CbGeAlD
Etodolac—Nausea—Dactinomycin—germ cell cancer	0.000295	0.00113	CcSEcCtD
Etodolac—Gastrointestinal pain—Etoposide—germ cell cancer	0.000294	0.00113	CcSEcCtD
Etodolac—Visual impairment—Methotrexate—germ cell cancer	0.000292	0.00112	CcSEcCtD
Etodolac—Vomiting—Ifosfamide—germ cell cancer	0.000289	0.00111	CcSEcCtD
Etodolac—Hypersensitivity—Cisplatin—germ cell cancer	0.000289	0.00111	CcSEcCtD
Etodolac—Rash—Ifosfamide—germ cell cancer	0.000287	0.0011	CcSEcCtD
Etodolac—Dermatitis—Ifosfamide—germ cell cancer	0.000287	0.0011	CcSEcCtD
Etodolac—Erythema multiforme—Methotrexate—germ cell cancer	0.000286	0.0011	CcSEcCtD
Etodolac—Urticaria—Etoposide—germ cell cancer	0.000285	0.00109	CcSEcCtD
Etodolac—Body temperature increased—Etoposide—germ cell cancer	0.000284	0.00109	CcSEcCtD
Etodolac—Abdominal pain—Etoposide—germ cell cancer	0.000284	0.00109	CcSEcCtD
Etodolac—Tinnitus—Methotrexate—germ cell cancer	0.000282	0.00108	CcSEcCtD
Etodolac—Asthenia—Cisplatin—germ cell cancer	0.000281	0.00108	CcSEcCtD
Etodolac—RXRA—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000275	0.00505	CbGpPWpGaD
Etodolac—Chills—Methotrexate—germ cell cancer	0.000272	0.00104	CcSEcCtD
Etodolac—Nausea—Ifosfamide—germ cell cancer	0.00027	0.00104	CcSEcCtD
Etodolac—Diarrhoea—Cisplatin—germ cell cancer	0.000268	0.00103	CcSEcCtD
Etodolac—Alopecia—Methotrexate—germ cell cancer	0.000268	0.00103	CcSEcCtD
Etodolac—Hypersensitivity—Etoposide—germ cell cancer	0.000265	0.00101	CcSEcCtD
Etodolac—Dysgeusia—Methotrexate—germ cell cancer	0.000258	0.000989	CcSEcCtD
Etodolac—Asthenia—Etoposide—germ cell cancer	0.000258	0.000988	CcSEcCtD
Etodolac—Pruritus—Etoposide—germ cell cancer	0.000254	0.000974	CcSEcCtD
Etodolac—PTGS2—C-MYB transcription factor network—H2AFZ—germ cell cancer	0.000253	0.00464	CbGpPWpGaD
Etodolac—PTGS1—brain—germ cell cancer	0.000251	0.00414	CbGeAlD
Etodolac—Vomiting—Cisplatin—germ cell cancer	0.000249	0.000955	CcSEcCtD
Etodolac—Vision blurred—Methotrexate—germ cell cancer	0.000249	0.000952	CcSEcCtD
Etodolac—Rash—Cisplatin—germ cell cancer	0.000247	0.000947	CcSEcCtD
Etodolac—Dermatitis—Cisplatin—germ cell cancer	0.000247	0.000946	CcSEcCtD
Etodolac—Diarrhoea—Etoposide—germ cell cancer	0.000246	0.000942	CcSEcCtD
Etodolac—Ill-defined disorder—Methotrexate—germ cell cancer	0.000245	0.000937	CcSEcCtD
Etodolac—Anaemia—Methotrexate—germ cell cancer	0.000244	0.000934	CcSEcCtD
Etodolac—PTGS1—lymph node—germ cell cancer	0.000243	0.004	CbGeAlD
Etodolac—SLC22A6—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000241	0.00443	CbGpPWpGaD
Etodolac—PTGS2—brain—germ cell cancer	0.00024	0.00395	CbGeAlD
Etodolac—Malaise—Methotrexate—germ cell cancer	0.000238	0.000911	CcSEcCtD
Etodolac—Dizziness—Etoposide—germ cell cancer	0.000238	0.00091	CcSEcCtD
Etodolac—Vertigo—Methotrexate—germ cell cancer	0.000237	0.000908	CcSEcCtD
Etodolac—Leukopenia—Methotrexate—germ cell cancer	0.000236	0.000904	CcSEcCtD
Etodolac—RXRA—Developmental Biology—KLF4—germ cell cancer	0.000235	0.00432	CbGpPWpGaD
Etodolac—Nausea—Cisplatin—germ cell cancer	0.000233	0.000892	CcSEcCtD
Etodolac—PTGS2—C-MYB transcription factor network—KITLG—germ cell cancer	0.000232	0.00427	CbGpPWpGaD
Etodolac—PTGS2—lymph node—germ cell cancer	0.000232	0.00382	CbGeAlD
Etodolac—Convulsion—Methotrexate—germ cell cancer	0.000228	0.000875	CcSEcCtD
Etodolac—Vomiting—Etoposide—germ cell cancer	0.000228	0.000875	CcSEcCtD
Etodolac—Rash—Etoposide—germ cell cancer	0.000227	0.000868	CcSEcCtD
Etodolac—Dermatitis—Etoposide—germ cell cancer	0.000226	0.000867	CcSEcCtD
Etodolac—Headache—Etoposide—germ cell cancer	0.000225	0.000862	CcSEcCtD
Etodolac—Arthralgia—Methotrexate—germ cell cancer	0.000224	0.00086	CcSEcCtD
Etodolac—Myalgia—Methotrexate—germ cell cancer	0.000224	0.00086	CcSEcCtD
Etodolac—Discomfort—Methotrexate—germ cell cancer	0.000222	0.00085	CcSEcCtD
Etodolac—Confusional state—Methotrexate—germ cell cancer	0.000217	0.000831	CcSEcCtD
Etodolac—Anaphylactic shock—Methotrexate—germ cell cancer	0.000215	0.000824	CcSEcCtD
Etodolac—Infection—Methotrexate—germ cell cancer	0.000214	0.000819	CcSEcCtD
Etodolac—Nausea—Etoposide—germ cell cancer	0.000213	0.000818	CcSEcCtD
Etodolac—Thrombocytopenia—Methotrexate—germ cell cancer	0.000211	0.000807	CcSEcCtD
Etodolac—Hyperhidrosis—Methotrexate—germ cell cancer	0.000208	0.000797	CcSEcCtD
Etodolac—Anorexia—Methotrexate—germ cell cancer	0.000205	0.000786	CcSEcCtD
Etodolac—Hypotension—Methotrexate—germ cell cancer	0.000201	0.00077	CcSEcCtD
Etodolac—RXRA—a6b1 and a6b4 Integrin signaling—HRAS—germ cell cancer	0.0002	0.00368	CbGpPWpGaD
Etodolac—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000196	0.000751	CcSEcCtD
Etodolac—Insomnia—Methotrexate—germ cell cancer	0.000195	0.000746	CcSEcCtD
Etodolac—Paraesthesia—Methotrexate—germ cell cancer	0.000193	0.00074	CcSEcCtD
Etodolac—Dyspnoea—Methotrexate—germ cell cancer	0.000192	0.000735	CcSEcCtD
Etodolac—Somnolence—Methotrexate—germ cell cancer	0.000191	0.000733	CcSEcCtD
Etodolac—Dyspepsia—Methotrexate—germ cell cancer	0.000189	0.000726	CcSEcCtD
Etodolac—Decreased appetite—Methotrexate—germ cell cancer	0.000187	0.000717	CcSEcCtD
Etodolac—Fatigue—Methotrexate—germ cell cancer	0.000186	0.000711	CcSEcCtD
Etodolac—Pain—Methotrexate—germ cell cancer	0.000184	0.000705	CcSEcCtD
Etodolac—RXRA—Gene Expression—NR0B1—germ cell cancer	0.000183	0.00336	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.00018	0.0033	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—CD9—germ cell cancer	0.000178	0.00328	CbGpPWpGaD
Etodolac—Feeling abnormal—Methotrexate—germ cell cancer	0.000177	0.000679	CcSEcCtD
Etodolac—RXRA—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000177	0.00325	CbGpPWpGaD
Etodolac—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000176	0.000674	CcSEcCtD
Etodolac—Urticaria—Methotrexate—germ cell cancer	0.000171	0.000655	CcSEcCtD
Etodolac—Body temperature increased—Methotrexate—germ cell cancer	0.00017	0.000652	CcSEcCtD
Etodolac—Abdominal pain—Methotrexate—germ cell cancer	0.00017	0.000652	CcSEcCtD
Etodolac—RXRA—Developmental Biology—SOX2—germ cell cancer	0.000166	0.00304	CbGpPWpGaD
Etodolac—ALB—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000161	0.00296	CbGpPWpGaD
Etodolac—ALB—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000159	0.00292	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—DNMT3L—germ cell cancer	0.000159	0.00291	CbGpPWpGaD
Etodolac—PTGS2—C-MYB transcription factor network—KIT—germ cell cancer	0.000159	0.00291	CbGpPWpGaD
Etodolac—Hypersensitivity—Methotrexate—germ cell cancer	0.000159	0.000607	CcSEcCtD
Etodolac—SLC22A6—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000158	0.0029	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000155	0.00285	CbGpPWpGaD
Etodolac—Asthenia—Methotrexate—germ cell cancer	0.000154	0.000592	CcSEcCtD
Etodolac—Pruritus—Methotrexate—germ cell cancer	0.000152	0.000583	CcSEcCtD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000152	0.00279	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—RARS—germ cell cancer	0.000148	0.00271	CbGpPWpGaD
Etodolac—Diarrhoea—Methotrexate—germ cell cancer	0.000147	0.000564	CcSEcCtD
Etodolac—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—germ cell cancer	0.000144	0.00265	CbGpPWpGaD
Etodolac—SLC22A6—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000143	0.00263	CbGpPWpGaD
Etodolac—Dizziness—Methotrexate—germ cell cancer	0.000142	0.000545	CcSEcCtD
Etodolac—PTGS2—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	0.000141	0.00259	CbGpPWpGaD
Etodolac—Vomiting—Methotrexate—germ cell cancer	0.000137	0.000524	CcSEcCtD
Etodolac—Rash—Methotrexate—germ cell cancer	0.000136	0.00052	CcSEcCtD
Etodolac—Dermatitis—Methotrexate—germ cell cancer	0.000136	0.000519	CcSEcCtD
Etodolac—Headache—Methotrexate—germ cell cancer	0.000135	0.000516	CcSEcCtD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000132	0.00243	CbGpPWpGaD
Etodolac—Nausea—Methotrexate—germ cell cancer	0.000128	0.00049	CcSEcCtD
Etodolac—ALB—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000125	0.0023	CbGpPWpGaD
Etodolac—PTGS2—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	0.000111	0.00204	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000108	0.00198	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—SLC2A3—germ cell cancer	0.000106	0.00195	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—SLC22A3—germ cell cancer	0.000105	0.00192	CbGpPWpGaD
Etodolac—ALB—Hemostasis—CD9—germ cell cancer	9.2e-05	0.00169	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—SLC2A3—germ cell cancer	9.03e-05	0.00166	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—SLC22A3—germ cell cancer	8.89e-05	0.00163	CbGpPWpGaD
Etodolac—PTGS2—C-MYB transcription factor network—MYC—germ cell cancer	8.73e-05	0.0016	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	8.56e-05	0.00157	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—CRABP1—germ cell cancer	8.53e-05	0.00157	CbGpPWpGaD
Etodolac—RXRA—Metabolism—SLC2A3—germ cell cancer	8.42e-05	0.00155	CbGpPWpGaD
Etodolac—RXRA—Metabolism—SLC22A3—germ cell cancer	8.3e-05	0.00152	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—AVP—germ cell cancer	8.29e-05	0.00152	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	8.2e-05	0.00151	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	8.08e-05	0.00148	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	8.02e-05	0.00147	CbGpPWpGaD
Etodolac—ALB—SLC-mediated transmembrane transport—AVP—germ cell cancer	7.44e-05	0.00137	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—SLC2A3—germ cell cancer	7.34e-05	0.00135	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—AVP—germ cell cancer	7.28e-05	0.00134	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—CRABP1—germ cell cancer	7.25e-05	0.00133	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—SLC22A3—germ cell cancer	7.23e-05	0.00133	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—TP53—germ cell cancer	7.03e-05	0.00129	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	6.93e-05	0.00127	CbGpPWpGaD
Etodolac—PTGS2—C-MYB transcription factor network—HRAS—germ cell cancer	6.85e-05	0.00126	CbGpPWpGaD
Etodolac—RXRA—Metabolism—CRABP1—germ cell cancer	6.76e-05	0.00124	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—MYC—germ cell cancer	6.65e-05	0.00122	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	6.59e-05	0.00121	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—SLC2A3—germ cell cancer	5.98e-05	0.0011	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—SLC22A3—germ cell cancer	5.89e-05	0.00108	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CRABP1—germ cell cancer	5.89e-05	0.00108	CbGpPWpGaD
Etodolac—PTGS2—Disease—SLC2A3—germ cell cancer	5.67e-05	0.00104	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	5.67e-05	0.00104	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—H2AFZ—germ cell cancer	5.56e-05	0.00102	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—TP53—germ cell cancer	5.46e-05	0.001	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CRABP1—germ cell cancer	4.8e-05	0.000882	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—SLC2A3—germ cell cancer	4.75e-05	0.000872	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—SLC22A3—germ cell cancer	4.68e-05	0.000859	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	4.52e-05	0.00083	CbGpPWpGaD
Etodolac—RXRA—Generic Transcription Pathway—MYC—germ cell cancer	3.99e-05	0.000732	CbGpPWpGaD
Etodolac—ALB—Metabolism—SLC2A3—germ cell cancer	3.84e-05	0.000705	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CRABP1—germ cell cancer	3.81e-05	0.0007	CbGpPWpGaD
Etodolac—ALB—Metabolism—SLC22A3—germ cell cancer	3.78e-05	0.000695	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—AVP—germ cell cancer	3.78e-05	0.000694	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	3.72e-05	0.000682	CbGpPWpGaD
Etodolac—PTGS2—Disease—FGF4—germ cell cancer	3.26e-05	0.000598	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—SLC2A3—germ cell cancer	3.14e-05	0.000577	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—SLC22A3—germ cell cancer	3.1e-05	0.000569	CbGpPWpGaD
Etodolac—ALB—Metabolism—CRABP1—germ cell cancer	3.08e-05	0.000566	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—HRAS—germ cell cancer	2.95e-05	0.000541	CbGpPWpGaD
Etodolac—PTGS2—Disease—H2AFZ—germ cell cancer	2.91e-05	0.000534	CbGpPWpGaD
Etodolac—PTGS2—Disease—KITLG—germ cell cancer	2.68e-05	0.000491	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CRABP1—germ cell cancer	2.53e-05	0.000464	CbGpPWpGaD
Etodolac—PTGS2—Disease—FGFR3—germ cell cancer	1.99e-05	0.000365	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—MYC—germ cell cancer	1.92e-05	0.000352	CbGpPWpGaD
Etodolac—PTGS2—Disease—KIT—germ cell cancer	1.83e-05	0.000335	CbGpPWpGaD
Etodolac—ALB—Hemostasis—TP53—germ cell cancer	1.38e-05	0.000253	CbGpPWpGaD
Etodolac—ALB—Hemostasis—HRAS—germ cell cancer	1.32e-05	0.000242	CbGpPWpGaD
Etodolac—PTGS2—Disease—MYC—germ cell cancer	1e-05	0.000184	CbGpPWpGaD
Etodolac—PTGS2—Disease—HRAS—germ cell cancer	7.89e-06	0.000145	CbGpPWpGaD
